Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger S Lo

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Molecular Oncology|December 19, 2013
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitorsHelena Escuin-Ordinas, Mohammad Atefi, Yong Fu, et al.
Nature Communications|May 23, 2014
Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitorsAnna A Marusiak, Zoe C Edwards, Willy Hugo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanismsKim H T Paraiso, H Eirik Haarberg, Elizabeth Wood, et al.
Nature Communications|March 8, 2012
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistanceHubing Shi, Gatien Moriceau, Xiangju Kong, et al.
Immunity|November 1, 2025
Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitorsMingming Wu, Shiyue Yang, Zhentao Yang, et al.
Cancer Cell|January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addictionGatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
Angewandte Chemie (International Ed. in English)|February 26, 2013
Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cellsShuang Hou, Libo Zhao, Qinglin Shen, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Molecular Oncology|December 19, 2013
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitorsHelena Escuin-Ordinas, Mohammad Atefi, Yong Fu, et al.
Nature Communications|May 23, 2014
Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitorsAnna A Marusiak, Zoe C Edwards, Willy Hugo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanismsKim H T Paraiso, H Eirik Haarberg, Elizabeth Wood, et al.
Nature Communications|March 8, 2012
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistanceHubing Shi, Gatien Moriceau, Xiangju Kong, et al.
Immunity|November 1, 2025
Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitorsMingming Wu, Shiyue Yang, Zhentao Yang, et al.
Cancer Cell|January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addictionGatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
Angewandte Chemie (International Ed. in English)|February 26, 2013
Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cellsShuang Hou, Libo Zhao, Qinglin Shen, et al.
Pageof 9